Related Experiment Video
Updated: Nov 16, 2025

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
Published on: July 2, 2016
Cellular and Immune Therapy for Treating HIV-1 Infection
Wei Li1, Qiqiang Zhou1, Lingbo Xia1
1The First Clinical Medical College of Nanchang University, Jiangxi, Nanchang, China.
Abstract:
HIV-1 infection has caused a number of deaths worldwide and remains a global health concern. Combined antiretroviral therapy (cART) inhibits viral replication, prevents CD4+ T cell loss, and thus slows HIV disease progression. However, cART does not eradicate HIV-1. Infected individuals must remain on treatment for their entire lives and treatment interruption will result in viral rebound.
Related Concept Videos
Tumor Immunotherapy
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses

